プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
dreifitöflur
dispersible tablets
最終更新: 2017-04-26
使用頻度: 8
品質:
exjade 125 mg dreifitöflur
exjade 125 mg dispersible tablets
最終更新: 2017-04-26
使用頻度: 3
品質:
56 dreifitöflur (14 x 4)
56 dispersible tablets (14 x 4)
最終更新: 2017-04-26
使用頻度: 1
品質:
exjade 125 mg dreifitöflur deferasirox
exjade 125 mg dispersible tablets deferasirox
最終更新: 2017-04-26
使用頻度: 3
品質:
exjade er fáanlegt sem dreifitöflur.
exjade is supplied as dispersible tablets.
最終更新: 2017-04-26
使用頻度: 1
品質:
deferasirox er einnig til sem dreifitöflur.
deferasirox also comes as “dispersible” tablets.
最終更新: 2017-04-26
使用頻度: 1
品質:
eu/1/06/356/001 28 dreifitöflur
eu/1/06/356/001 28 dispersible tablets
最終更新: 2017-04-26
使用頻度: 9
品質:
taktu votubia dreifitöflur einu sinni á sólarhring.
take votubia dispersible tablets once a day.
最終更新: 2017-04-26
使用頻度: 1
品質:
notið votubia dreifitöflur einungis sem mixtúru, dreifu
take votubia dispersible tablets as an oral suspension only
最終更新: 2017-04-26
使用頻度: 1
品質:
exjade filmuhúðaðar töflur hafa meira aðgengi en exjade dreifitöflur.
exjade film-coated tablets demonstrate higher bioavailability compared to the exjade dispersible tablet formulation.
最終更新: 2017-04-26
使用頻度: 1
品質:
ekki hætta að taka votubia dreifitöflur nema læknirinn segi þér að gera það.
do not stop taking votubia dispersible tablets unless your doctor tells you to.
最終更新: 2017-04-26
使用頻度: 1
品質:
votubia 2 mg dreifitöflur eu/1/11/710/009-011
votubia 2 mg dispersible tablets eu/1/11/710/009-011
最終更新: 2017-04-26
使用頻度: 3
品質:
exjade 125 mg dreifitöflur exjade 250 mg dreifitöflur exjade 500 mg dreifitöflur deferasirox
exjade 125 mg dispersible tablets exjade 250 mg dispersible tablets exjade 500 mg dispersible tablets deferasirox
最終更新: 2017-04-26
使用頻度: 1
品質:
fletti-þrýstiþynnur sem innihalda 14 dreifitöflur, öskjur innihalda 56 dreifitöflur.
peel-push blisters containing 14 dispersible tablets; cartons contain 56 dispersible tablets.
最終更新: 2017-04-26
使用頻度: 1
品質:
tracleer 32 mg dreifitöflur innihalda aspartam (e951) sem breytist í fenýlalanín.
tracleer 32 mg dispersible tablets contain a source of phenylalanine (aspartame – e951).
最終更新: 2017-04-26
使用頻度: 1
品質:
fimmtíuogsex sjúklingar yngri en 6 ára tóku þátt í lykilrannsókninni og 28 þeirra fengu deferasirox dreifitöflur.
fifty-six patients under the age of 6 years participated in this pivotal study, 28 of them receiving deferasirox dispersible tablets.
最終更新: 2017-04-26
使用頻度: 1
品質:
ef þú ert að skipta af meðferð með filmuhúðuðum töflum yfir á þessar dreifitöflur þarf að breyta skammtinum hjá þér.
if you are switching from the film-coated tablets to these dispersible tablets, you will need an adjustment of the dose.
最終更新: 2017-04-26
使用頻度: 1
品質:
votubia 2 mg dreifitöflur eru hvítar eða fölgular, kringlóttar, flatar töflur með sniðbrún, án deiliskoru.
votubia 2 mg dispersible tablets are white to slightly yellowish, round, flat tablets with a bevelled edge and no score.
最終更新: 2017-04-26
使用頻度: 3
品質:
að auki verður sérstakt bréf sent læknum og lyfjafræðingum með upplýsingum um hvenær exjade dreifitöflur verða teknar af markaði í evrópu.
additionally, prescribers and pharmacists will be informed via a specific letter regarding the timelines for removing exjade dispersible tablets from the eu market.
最終更新: 2017-04-26
使用頻度: 1
品質:
heildaraðgengi (auc) deferasirox (sem dreifitöflur) er um 70% samanborð við gjöf í bláæð.
the absolute bioavailability (auc) of deferasirox (dispersible tablet formulation) is about 70% compared to an intravenous dose.
最終更新: 2017-04-26
使用頻度: 1
品質: